Drug Utilization Review Committee

Notice of Public MeetingState of AlaskaDepartment of HealthDivision of Health Care ServicesThe Division will be sponsoring the following meeting to address the Drug Utilization Review. Please note, this meeting will be available via teleconference only. Please register for the meeting by using the link below: https://events.teams.microsoft.com/event/c98fc804-3bb0-4308-aff4-a48184d314dc@34c95ba7-5ec6-4527-bc5e-b33b58104992After registering, you will receive a confirmation email containing information about joining the webinar. The Drug Utilization Review Committee will meet Friday, November 21 2025 at 1:00 p.m. Agendas are posted on the Health Care Services Drug Utilization website https://health.alaska.gov/dhcs/Pages/pdl/drugutilizb_pdl.aspx. If you would like to join via teleconference, please dial 1-844-730-9010. Webinar ID: 950 845 443# Any pharmaceutical manufacturer may submit unsolicited material related to the agenda items by utilizing the Clinical Submission form. Clinical Submissions will be accepted until November 7, 2025 at 4:00pm AK local time. Forms may be found at: https://health.alaska.gov/en/division-of-health-care-services/medicaid-pharmacy-and-therapeutics/ Any member of the public, including health care professionals, may submit unsolicited material related to the agenda items by sending an email to doh.hcs.pharmacy.info@alaska.gov or via mail to 4601 Business Park Blvd, Bldg K, Anchorage, AK 99503. A conflict of interest form must accompany any submission and can be found at: https://health.alaska.gov/dhcs/Documents/pharmacy/forms/Alaska-Medicaid-Clinical-Coverage-Review-Request-Disclosure-Form.pdf. Submissions should be received no later than November 19, 2025 to allow inclusion in the meeting. If you cannot join the webinar and would like to join via teleconference, please dial toll free 1-844-730-9010 Webinar ID: 950 845 443#. Individuals with disabilities who need special accommodations in order to participate should contact Matthew Parrott at 907.334.2425 no later than 2:00 p.m., Wednesday, November 19, 2025